Vaccine development
AID researchers possess a strong translational record in the field of vaccinology, notably in the development of new vaccines, the development of the needle-less nanopatch vaccine delivery system and the formulation of novel adjuvants.
We will utilise these technologies to develop new vaccines against a range of infectious disease agents.
A pledge to AID goes directly into the research of issues that impact the lives of many people and their families.